Plain-English translation of NCT06435585 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Researchers want to understand why some people with heart failure respond well to treatment while others don't. By collecting blood and urine samples from 5,000 patients across Sweden, scientists will study your genes and biological markers to discover what determines treatment success and help doctors personalize care in the future.
Currently, doctors cannot reliably predict which patients will benefit most from heart failure treatments. This research aims to identify genetic and biological clues that could help tailor treatment plans and improve outcomes for future patients.
You likely qualify if…
You likely don't qualify if…
You will visit a hospital or clinic in Sweden where staff will collect blood and urine samples. Your samples will be stored and analyzed to look at your genes and biological markers related to heart failure. This is a one-time sample collection; you do not need to take any experimental medication or make major lifestyle changes as part of this study.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Sweden
Collaborators
University Hospital, Linkoeping
Enrollment target
~5,000 participants
Started
February 2021
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Camilla Hage, Ass prof
Karolinska University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.